Skip to main content
. 2015 Jul 15;8(7):11708–11717.

Figure 4.

Figure 4

Expressions levels of mdr1 and bcr-abl mRNA in the experimental animals were significantly lower than in the control animals. A: mdr1; B: bcr/abl; C: β-actin; line 1, Marker; line 2 and 4, control animal group; line 3 and 5, treated animal group. Note: Compared with the mice treated with adriamycin (control group), expression levels of human mdr1 and bcr/abl mRNA declined in mice treated with CA combined with adriamycin (experimental group).